Intrinsic Value

Hyloris Pharmaceuticals SA (HYL.BR)

12 €

-0.10 (0.00%)

Enterprise Value -7,252,754.77
Net Debt -24.90
Equity Value -7,252,729.87
Shares Outstanding 28.15
Equity Value Per Share -257,678.51



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt